Previous Close | 9.87 |
Open | 10.24 |
Bid | 0.00 |
Ask | 0.00 |
Strike | 20.00 |
Expire Date | 2024-06-21 |
Day's Range | 9.80 - 10.24 |
Contract Range | N/A |
Volume | |
Open Interest | 9 |
Investors need to pay close attention to Supernus (SUPN) stock based on the movements in the options market lately.
SPN-817 is a novel, first-in-class highly selective acetylcholinesterase (AChE) inhibitor for epilepsy Company to host webcast today at 4:30 p.m. ET to discuss the interim data ROCKVILLE, Md., May 23, 2024 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, today announced data from the planned interim analysis of the exploratory open-label Pha
Despite Challenges, Company Shows Promising Growth in Key Areas